课题基金 / 基金详情

Immunovirological determinants of breakthrough COVID-19 disease in vaccinated or previously infected individuals

Immunovirological determinants of breakthrough COVID-19 disease in vaccinated or previously infected individuals
已接种疫苗或既往感染者中突破性 COVID-19 疾病的免疫病毒学决定因素
批准号：
445444
负责人：
Kaufmann Daniel E
金额：
$69.66万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-04-01 至 2026-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=445444&lang=en
关键词：
Covid-19 Host Determinants Of Disease Immune Predictors Of Disease Risk Personalized Medicine Protective Antiviral Immunity Sars-Cov-2 Sars-Cov-2 Reinfection Sars-Cov-2 Vaccines Sars-Cov-2 Variants Systems Biology

项目摘要

项目成果

Kaufmann Daniel E的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The pace of development of effective SARS-CoV-2 vaccines and their deployment have been truly remarkable, and unprecedented in the history of infectious diseases. However, many expert epidemiologists expect that SARS-CoV-2 will become endemic worldwide, t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID-19 disease
Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID-19 disease
The molecular basis of persistent HIV-specific CD4 T cell dysfunction
Influence of pre-existing HIV cross-reactive CD4 T cells on vaccine responses to new Env immunogens